Product Description
Overall, the global treatment planning software market was valued at $28.4 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $35.1 million.
The full report suite includes treatment planning software. The market is analyzed as a whole and not further segmented.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- COVID-19 Impact Analysis
GLOBAL TREATMENT PLANNING SOFTWARE MARKET TRENDS
- In 2023, Dentsply Sirona led the treatment planning software market, driven by its digital transformation efforts. Serving specialists like periodontists and oral surgeons, it maintains leadership despite competition from lower-priced options like Anatomage.
- Envista ranked second, with its premium implants boosting treatment planning software sales. NobelClinican™ is offered in single license and full network versions, often discounted with large implant purchases. Envista expects steady software sales and growth in maintenance fees.
- Straumann Group’s CoDiagnostiX™ software gained popularity, supported by its compatibility with various manufacturers and ability to order surgical guides from local labs. This aligns with Straumann’s strong overall performance in digital dentistry.
Global Treatment Planning Software Market Segmentation Summary
- Treatment Planning Software Market
Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Data | 2020-2022 |
Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |